contributor
- Calder, Christopher Principal Investigator - 2005
A Double- Blind, Placebo- Controlled Study of VP4896 for the Treatment of Mild-to-Moderate Alaheimer’s Disease, Voyager Pharmaceuticals.
Grant
- Affiliation